The objective was to elucidate hemodynamic adaptation in very low birth weight (Ͻ1500 g) infants after intrauterine growth retardation. 31 growth-retarded (SGA, birth weight Ͻ-2 SD) and 32 appropriate for gestational age (AGA, birth weight within Ϯ 1 SD range) infants were enrolled. In SGA infants, the diastolic diameters of the interventricular septum and the left ventricle were increased, and serum brain natriuretic peptide (BNP) was elevated. Left ventricular output (LVO) of the AGA infants increased from 150 Ϯ 28 to 283 Ϯ 82 mL/kg/min during the study (p Ͻ 0.01). The SGA infants had a higher initial LVO than the AGA infants (243 Ϯ 47 versus 150 Ϯ 28 mL/kg/min, p Ͻ 0.05), but did not show further LVO increase during the study period. Red cell (RCV) and blood (BV) volume were assessed by Hb subtype analysis, when packed donor red cells were transfused. RCV and BV did not differ between the groups initially, but RCV increased by 18% and BV by 29% in the AGA group during the first 3 d. On day 3, AGA infants had larger BV than the SGA infants (88 Ϯ 5 versus 73 Ϯ 12 mL/kg, p Ͻ 0.05). In conclusion, cardiac hypertrophy, elevated initial LVO and BNP of the SGA infants suggest increased cardiac workload after intrauterine growth retardation. Based on the BV and RCV data, blood volume regulation may also be impaired. The data suggest that SGA preterm infants may be exposed to an increased risk of circulatory failure during early adaptation. Intrauterine growth retardation is associated with increased neonatal mortality, perinatal complications and long-term neurologic sequelae in preterm infants (1), as well as compromised cardiovascular adaptive capacity already in utero (2-4). However, few data have been reported regarding early circulatory adaptation after intrauterine growth retardation. In addition to myocardial performance, adequate intravascular volume is essential for successful postnatal cardiovascular adaptation. Largely due to the lack of applicable methodology, present knowledge on intravascular volume of preterm infants in general is scarce, and the effect of growth retardation on circulating volume has not been studied.
Intrauterine growth retardation is associated with increased neonatal mortality, perinatal complications and long-term neurologic sequelae in preterm infants (1) , as well as compromised cardiovascular adaptive capacity already in utero (2) (3) (4) . However, few data have been reported regarding early circulatory adaptation after intrauterine growth retardation. In addition to myocardial performance, adequate intravascular volume is essential for successful postnatal cardiovascular adaptation. Largely due to the lack of applicable methodology, present knowledge on intravascular volume of preterm infants in general is scarce, and the effect of growth retardation on circulating volume has not been studied.
The aim of the present study was to test the hypothesis that fetal growth retardation alters the pattern of early hemodynamic adaptation of very low birth weight infants. During the first two weeks of life, left ventricular function and dimensions were assessed by echocardiography in SGA infants and AGA control infants. A circulating indicator of ventricular dysfunction, BNP, was also measured. RCV and BV were determined by a method based on dilution of autologous HbF by donor HbA when red cells were transfused based on clinical judgment. Hemodynamic evaluation was also performed by using indirect indices applied in routine clinical work.
METHODS

Patients.
All infants in the study were born in the maternal unit of the Helsinki University Hospital and treated in the neonatal intensive care unit of the same hospital. Infants with a birth weight less than 1500 g and indwelling arterial lines were enrolled if the birth weight was less than Ϫ2 SD (SGA) or within Ϯ1 SD range (AGA). Infants with acute birth asphyxia (umbilical artery pH less than 7.1), chromosomal abnormalities and major congenital heart disease were excluded from the study. Gestational ages were determined by fetal ultrasonography. The routine prenatal follow-up included fetal weight estimation by ultrasonographical assessment of abdominal circumference and early second-trimester fetal biparietal diameter measurement, determinations of umbilical blood flow, and cardiotocography applied for long-term fetal heart rate monitoring based on clinical judgment.
Monitoring. Systolic and mean arterial blood pressure, heart rate, and oxygen saturation were continuously monitored (Hewlett Packard Neonatal Component Monitoring System). Capillary refill time was recorded as described by Strozik et al. (5) . The monitored values were recorded immediately before the echocardiography was performed.
Echocardiography and biochemical measurements. To obtain the circulating volume measurements simultaneously with the echocardiography, the patients were studied when packed donor red cells (10 mL per kg) were transfused based on clinical indication. The data from days 1, 2 and 3 were analyzed separately, the data from days 4 -6 (mean 5) and day 7-14 (mean 10) were pooled. The study was repeated in the infants who received another transfusion with the arterial line still indwelling. LVO and stroke volume (SV) were measured before transfusion (all measurements performed by the same cardiologist) using an Acuson 128/XP10 scanner (7 MHz). The flow velocity integral of the maximal velocity in the ascending aorta (suprasternal view) was measured with continuous-wave Doppler. The internal diameter of aortic annulus was measured using frame-by-frame analysis of the 2-D image in the parasternal long axis view. LVO was calculated from the equation: LVOϭcross sectional aortic area (cm 2 ) multiplied by flow velocity integral (cm) multiplied by heart rate per minute. The presence of ductus arteriosus was defined using color Doppler. End-diastolic diameter of the left ventricle (LVEDD), diastolic inter ventricular thickness (IVSD), left ventricular shortening fraction (LVSF) and ejection fraction (LVEF) were measured by M-mode from parasternal long axis view of the ventricle at the junction of the mitral valve leaflets and papillary muscles.
BNP was measured by RIA after extraction of the samples with SepPak C 18 cartridges as described previously (6) . The sensitivity of the assay was 0.3 fmol/tube. The within and between assay coefficients of variation were Ͻ10 and Ͻ15%, respectively. The assay does not cross-react with atrial or C-type natriuretic peptide (Ͻ0.1%). With the method, the BNP level in the plasma of healthy adults was 3.8 Ϯ 3.4 pmol/L. In healthy neonates, plasma BNP concentration is highest at 0 d of age (up to 30 times higher than the adult level) and decreases thereafter reaching the adult level at three months of age (7) .
The volume assessment was performed by a modification of the Hb subtype method described by Phillips et al. (8) . An arterial blood sample was drawn before transfusion (immediately after echocardiography), and 15 min after the transfusion.
Hb subtypes HbF and HbA were separated by liquid chromatography by using a PolyCAT A-cation exchange column (PolyLC Inc.), and determined by Applied Biosystems absorbance detector as previously described (9) . RCV and BV were calculated based on the change in the relative amounts of Hb subtypes caused by the transfusion.
Statistics. The data were analyzed by one-way ANOVA, the two-tailed Student's t test, the 2 test and the Wilcoxon rank sum test. A p value Ͻ0.05 was considered significant.
Ethical considerations. The study was approved by the hospital ethical committee and was conducted according to the principles of the Declaration of Helsinki. Informed written parental consent was obtained before enrollment.
RESULTS
Characteristics of the study population are shown in Table 1 . Preeclampsia was the most common cause of growth retardation. There were no cases of maternal malnutrition in the study population. Cardiac diameters in relation to weight were increased after growth restriction (Fig. 1) . Serum BNP correlated significantly with both IVSD (Pearson correlation 0.727, significant at the 0.01 level) and LVEDD (Pearson correlation 0.317, significant at the 0.05 level). Serum BNP was 27 Ϯ 13 pmol/L in the AGA and 48 Ϯ 53 pmol/L in SGA infants (p Ͻ 0.05).
Initially, LVO was larger in the SGA than the AGA infants (243 Ϯ 47 versus 150 Ϯ 28 mL/kg/min, p Ͻ 0.05). A gradual increase of LVO was observed during the study period in the AGA infants (LVO was increased by 39% on day 3 and by 89% in the end of the study), whereas no LVO increase occurred in the SGA infants (Fig. 2) . This difference was also observed in the infants studied repeatedly: in the 12 AGA infants studied twice LVO was 200 Ϯ 54 mL/kg/min in the first and 247 Ϯ 68 mL/kg/min in the second assessment (p Ͻ 0.05), whereas in the 15 SGA infants studied twice LVO remained similar (224 Ϯ 105 versus 246 Ϯ 57 mL/kg/min, NS). There was a close correlation of LVO to SV (Pearson correlation 0.927, p Ͻ 0.01), but no significant correlation with mean arterial blood pressure and capillary refill time. Similarly to LVO, SV on day 1 was significantly greater in the SGA compared with the AGA infants (1.51 Ϯ 0.32 versus 0.95 Ϯ 0.17, p Ͻ 0.05), and did not increase in the SGA infants thereafter. The indices of contractility did not differ between the groups: mean LVSF of all measurements was 36.5 Ϯ 6.2% in the AGA and 36.7 Ϯ 6.2% in the SGA infants, mean LVEF 70.4 Ϯ 7.9% and 70.8 Ϯ 8.6%, respectively. At the time of the study mean heart rate was 158 Ϯ 15.8 beats per minute in the AGA infants, and 158 Ϯ 16.4 in the SGA infants. No significant differences were observed when data from the different study times were analyzed separately. 13 AGA infants and 18 SGA infants were treated with catecholamines (NS difference). RCV and BV did not differ between the groups initially, but both volumes increased in the AGA infants during the first 3 d of life, and were significantly higher on day 3 than on day 1 ( Table 2 ). Compared with day 1, RCV and BV remained unaltered till the end of the first week in the SGA group. RCV correlated with hematocrit (Pearson correlation 0.569, p Ͻ 0.01) but not with LVO, systolic blood pressure, mean arterial blood pressure, heart rate and capillary refill time. BV correlated significantly only to RCV (Pearson correlation 0.892, p Ͻ 0.01). There were no significant differences in the indirect indices of hemodynamics between the AGA and SGA infants.
DISCUSSION
Echocardiographic studies have shown a redistribution of circulation diverting oxygenated blood from other tissues to sustain the growth of the brain, as well as a shift of cardiac flow in favor of the left side of the heart in growth-retarded fetuses (10 -12) , but the immediate postnatal cardiovascular consequences of growth restriction have not been elucidated. The present study shows that fetal growth restriction is associated with alterations in early hemodynamic adaptation in low birth weight infants. Increased ventricular output and cardiac hypertrophy occur in fetal animals in chronic anemia and hypoxia (13, 14) , and increased LVO and decreased ratio of right to left ventricular output has been reported in growth-retarded human fetuses (12) . This redistribution of the ventricular outputs can be understood in the light of the fact that the output of the fetal left ventricle is directed mainly to the brain, whereas the output of the right ventricle is directed to the lower body and placenta. A redistribution of cardiac output in favor of the left heart is therefore in accordance with the brain-sparing effect in intrauterine growth retardation, and most likely due to selective changes in peripheral vascular resistance (15) . The septal and left ventricular hypertrophy observed in SGA infants in the present study could be explained by increased left ventricular work load in utero resulting from a shift in the left-to-right output ratio. Another possible explanation for an increased left ventricular afterload is impaired systemic vascular resistance. Low birth weight has been reported to be linked to decreased endothelium-dependent vascular dilatation later in life (16, 17) . Furthermore, it has recently been suggested that this association is more likely due to growth restriction than to a low birth per se (18) . We did not find any significant differences in LVEF and LVSF between the AGA and SGA infants, the mean values for these indices being well in the normal range (ϭ27% or more for LVSF, 55% or more for LVEF) in both groups. Thus the altered LVO after intrauterine growth retardation is more likely explained by changes of vascular resistance than contractility.
Increased cardiac output has been observed in SGA infants on day 1 also by Martinussen et al. (19) . The higher initial LVO in the SGA infants could also be due to compensation of fetal tissue hypoxia. Although augmented LVO may counter- balance for some sequelae of growth retardation, SGA infants may have limited capacity for further cardiac adaptation, since they are unable to increase their LVO postnatally, in contrast to the AGA infants. Interestingly, elevated cardiac output has been observed in a prospective study in pregnant women already before the clinical diagnosis of preeclampsia (20) , and a high cardiac output has been proposed to act as a compensatory mechanism for decreased uteroplacental circulation (21) . Our data suggest that similar mechanisms of cardiac compensation may be activated in the fetuses and the mothers in pregnancies complicated by preeclampsia. Since there was no initial difference in the intravascular volume between the groups, it is not likely that the LVO increase was due to an increased preload. Respiratory distress syndrome and persistent ductus arteriosus influence LVO of preterm infants (22) , but the altered pattern of LVO development observed in the present study cannot be explained by differences in respiratory or ductal factors, nor by differences in vasopressor treatment, since these did not differ significantly between the groups at the studied points of time.
Cardiac hypertrophy observed in the SGA infants is in accordance with the previously reported hypertrophy of both ventricles in growth-retarded fetuses (3, 4) . The most probable mechanism of this hypertrophy is prolonged exposure to an increased myocardial workload, which could also account for the elevated BNP in the SGA infants observed in the present study. Circulating BNP levels are known to correlate with ventricular dysfunction, left ventricular wall thickness and left ventricular mass (e.g. refs. 23, 24) . Together the present observations, altered postnatal pattern of LVO, cardiac hypertrophy and increased BNP suggest that SGA infants are exposed to a significant cardiovascular stress in utero. They may thus be more susceptible to circulatory failure than AGA infants. Accumulating recent evidence has linked fetal growth retardation to cardiovascular diseases in adult life (Barker's hypothesis, ref. 25). Therefore it is tempting to speculate that the hemodynamic changes observed in the present study may be permanent. Further study is needed to establish whether this is the case.
Intravascular volume in relation to intrauterine growth has been previously studied only in polycythemic infants receiving a partial plasma exchange transfusion, in whom circulating volume was larger in SGA than AGA infants, but most of the SGA infants included in the study were full-term (26). Brans et al. (27) observed no alterations after intrauterine growth deviations in the plasma and blood volumes in appropriately grown, growth-retarded and macrosomic full or near-term polycythemic infants studied within 32 h of birth. The Hb subtype method allows RCV and BV assessment in any newborn requiring a red cell transfusion (8) . Analogously to their postnatal profile of LVO, the SGA infants failed to increase their blood volume during the first days of life. This suggests that intravascular volume regulation may also be impaired by fetal growth restriction.
In contrast to the echocardiographic and biochemical assessment, conventional indirect indices of hemodynamics (blood pressure, heart rate and capillary refill time) did not reveal any differences between the study groups. This emphasizes that a subclinical but potentially significant cardiovascular compromise cannot be detected simply by monitoring these parameters. Of the techniques applied in the present study, echocardiographic measurement of cardiac output is the most practical addition to the clinical setting. The usefulness of the Hb subtype method for BV estimation in routine care is limited by two factors: it can only be performed when a red cell transfusion is given, and the time needed for sample preparation and separation of the Hb subtypes is too long for most clinical purposes.
CONCLUSION
In conclusion, intrauterine growth retardation is associated with alterations of cardiovascular adaptation as well as septal and left ventricular hypertrophy in newborn low birth weight infants. Although the data indicate that SGA fetuses are capable of considerable cardiovascular compensation, they may still be exposed to an increased risk of circulatory failure later. It still remains to be established whether the hemodynamic changes observed in SGA newborns are permanent.
